Sonoma Pharmaceuticals
SNOA
#11036
Rank
C$7.74 M
Marketcap
C$1.62
Share price
0.88%
Change (1 day)
-68.45%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2026 (TTM): -C$1.95 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are C$21.92 Million. In 2025 the company made an earning of -C$3.93 Million, an increase over its 2024 earnings that were of -C$6.34 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$1.95 Million-50.49%
2025 -C$3.93 Million-38.02%
2024 -C$6.34 Million0.54%
2023 -C$6.3 Million-31.5%
2022 -C$9.2 Million16.86%
2021 -C$7.87 Million194.32%
2020 -C$2.68 Million-58.76%
2019 -C$6.48 Million-65.66%
2018 -C$18.88 Million4.84%
2017 -C$18.01 Million-2.17%
2016 -C$18.41 Million32.12%
2015 -C$13.93 Million-307.74%
2014 C$6.7 M-197.5%
2013 -C$6.88 Million
2010 -C$10.75 Million-14.02%
2009 -C$12.5 Million-57.28%
2008 -C$29.25 Million-8.03%
2007 -C$31.81 Million3.85%
2006 -C$30.63 Million39.31%
2005 -C$21.99 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-C$0.12 Billion 5,577.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-C$25.76 Million 1,191.32%๐Ÿ‡บ๐Ÿ‡ธ USA